Human medicines European public assessment report (EPAR): Bekemv, eculizumab, Date of authorisation: 19/04/2023, Revision: 6, Status: Authorised
Minutes of the COMP meeting 4-6 November 2025
3-year rolling work plan for the Quality Innovation Group (QIG) 2026-2028
Medicine evaluation figures
Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 25, Status: Authorised
Human medicines in 2025
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure
European Medicines Agency post-authorisation procedural advice for users of the centralised procedure: document with tracked changes
PSUSA/00000851/202503
Human medicines European public assessment report (EPAR): Roctavian, valoctocogene roxaparvovec, Date of authorisation: 24/08/2022, Revision: 10, Status: Authorised